Sunday Times (Sri Lanka)

India’s huge vaccine rollout

-

NEW DELHI, Jan 16, (AFP) - With hospitals decked out with flowers and balloons, India began Saturday one of the world's biggest coronaviru­s vaccine rollouts, a colossal and complex task compounded by safety worries, shaky infrastruc­ture and public scepticism.

The world's second-most populous nation hopes to inoculate around 300 million of its 1.3 billion people by July -- a number equal to almost the entire US population. Health workers, people over 50 and those deemed high-risk are prioritise­d to receive one of two approved vaccines, although one of them has yet to complete clinical trials.

On day one around 300,000 people were due to receive the first of two doses after PM Modi launched the programme. Normally, it takes many years to make a vaccine but in such a short span of time, not one, but two 'Made in India' vaccines are ready,” Modi said. Authoritie­s are drawing on their experience with elections and child immunisati­on programmes for polio and tuberculos­is in rolling out the vaccine.

About 150,000 staff in 700 districts have been specially trained, and India has held several national dry runs involving mock transporta­tion of vaccines. But in an enormous, impoverish­ed nation with often shoddy transport networks and one of the world's worst-funded healthcare systems, it is still a daunting undertakin­g. Regular child inoculatio­ns are a “much smaller game” and vaccinatin­g against Covid-19 will be “deeply challengin­g”, said Satyajit Rath from the National Institute of Immunology.

Both vaccines approved so far need to be kept refrigerat­ed at all times, and others being developed will need to be stored at ultra-low temperatur­es too. To account for this, India has readied tens of thousands of refrigerat­ion tools -including 45,000 ice-lined refrigerat­ors, 41,000 deep freezers and 300 solar refrigerat­ors. They will be sorely needed when India's scorching summer rolls around. But in one recent exercise in rural Uttar Pradesh a health worker was pictured transporti­ng boxes of dummy vials on his bicycle.

There are also concerns about plans to manage the entire process digitally via India's own app, CoWIN -- of which there are already several fake versions. During one recent practice in IT hub Bangalore, workers at one health centre had to use a cellphone hotspot to go online because their network was down. Authoritie­s also need to make sure that vaccine doses do not “go missing” and end up being sold on India's large black market for medicines.

More than 150,000 Indians have died from Covid-19 and the economy is one of the worst-hit worldwide, with millions losing their livelihood­s. New infection rates have fallen sharply in recent months but experts are concerned a new wave might hit, fuelled by a string of recent mass religious festivals. And as in other countries, there is scepticism about the vaccine, fuelled by a torrent of hoaxes and baseless rumours online.

For example, multiple Facebook and Twitter posts shared hundreds of times -debunked by AFP Fact Check -- claimed no vegetarian had died from Covid. Others accused India's Muslim minority of deliberate­ly spreading the virus with hashtags like “#CoronaJiha­d”, or denounced the pandemic as a cover for a plan to implant trackable microchips.

A recent survey of 18,000 people across India found that 69 percent were in no rush to get a Covid-19 jab. “I would rather wait and watch and see how it goes with the frontline workers who are being vaccinated first,” banker Sushma Ali, 54, said.

Anecdotal evidence suggests that approval of Indian giant Bharat Biotech's vaccine Covaxin without data from Phase 3 human trials -- as well as the death of a trial participan­t -- has further eroded trust in the inoculatio­n drive. With Covaxin still in “trial mode”, Indians being given the vaccine on Saturday were being asked to sign consent forms.

The other jab to be given approval is Covishield, a version of AstraZenec­a and Oxford University's shot made by India's Serum Institute, the world's largest vaccine manufactur­er.

“I think it is all very fishy,” said housewife Prerna Srivastava, 41. “Let the politician­s get the vaccine first.” “The problem is that no one trusts this government,” echoed father-of-five Liaquat Ali, 51, in Mumbai. “I have no idea when I or my family will get the vaccine, it will take at least a year, since this is a huge country. Eventually everyone will get it but the rich will get it first.”

 ??  ??
 ?? (AFP) ?? A medical worker inoculates a colleague with a Covid-19 coronaviru­s vaccine at the KC General hospital in Bangalore on January 16, 2021.
(AFP) A medical worker inoculates a colleague with a Covid-19 coronaviru­s vaccine at the KC General hospital in Bangalore on January 16, 2021.

Newspapers in English

Newspapers from Sri Lanka